Johnson & Johnson reports durable two-year remission data for TREMFYA in Crohn's disease

Trellus Health signs contract with leading global CRO and expands clinical trial offerings

Genentech's Gazyva (obinutuzumab) receives US FDA approval to treat adults with lupus nephritis

AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps

CStone announces Phase I CS2009 data at ESMO 2025

Autonomix Medical secures new US patent to expand precision nerve-targeted therapies

Oxford BioDynamics and UEA develop 96% accurate blood test for Chronic Fatigue Syndrome

Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio

Avobis Bio's AVB-114 implantable cell therapy granted US FDA RMAT designation for Crohn's perianal fistulas

Celltrion launches AVTOZMA IV in the United States following FDA approval

Novartis to launch US direct-to-patient platform for Cosentyx

Vascarta completes VAS-101 osteoarthritis clinical trial

Sen-Jam Pharmaceutical and KVK Tech complete final development deliverables for SJP-002C

OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University

ResVita Bio completes face-to-face Pre-IND meeting with FDA for RVB-003